NewsBenzingaアルボテック、Humiraバイオシミラー「SIMLANDI」の米国向け製造能力追加についてFDAの承認を取得――レイキャビク拠点で原薬生産能力を倍増 アルボテック、Humiraバイオシミラー「SIMLANDI」の米国向け製造能力追加についてFDAの承認を取得――レイキャビク拠点で原薬生産能力を倍増 Benzinga 2026.10.05 08:21 (GMT+0) Open on Benzinga Other news Morgan Stanley Upgrades Wells Fargo to Overweight, Maintains Price Target to $102 Vivek Ramaswamy-Founded Strive to Acquire More Bitcoin? Here's What the CEO Hinted at BMO Capital Initiates Coverage On Vertiv Holdings with Outperform Rating, Announces Price Target of $329 BMO Capital Initiates Coverage On nVent Electric with Outperform Rating, Announces Price Target of $212 Sweetgreen Q2 2026 Earnings Call: Complete Transcript Gen Digital Q1 2027 Earnings Call: Complete Transcript
BMO Capital Initiates Coverage On Vertiv Holdings with Outperform Rating, Announces Price Target of $329
BMO Capital Initiates Coverage On nVent Electric with Outperform Rating, Announces Price Target of $212